BeyondSpring Inc. BYSI
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-03-09
BeyondSpring Inc. statistics & valuation
Market cap$69.5M
Return on capital-72.4%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | -2756.4% | -4903.0% | -35672.8% | — | — | — | — |
| Net margin | — | — | — | -2463.3% | -4750.5% | -33873.9% | — | — | — | — |
| FCF margin | — | — | — | -2035.4% | -3707.3% | -24331.7% | — | — | — | — |
| Return on assets | -3.9% | -32.4% | -84.8% | -72.0% | -78.6% | -52.1% | -85.5% | -776.9% | -279.5% | -80.6% |
| Return on equity | 3.1% | 33.8% | 59.5% | 236.3% | -240.5% | -69.0% | -122.3% | 584.8% | -327.3% | -97.7% |
| Debt / equity | — | — | — | — | 0.00× | 0.02× | 0.05× | — | — | — |
| Current ratio | 1.54 | 2.60 | 2.31 | 5.24 | 4.96 | 8.24 | 4.06 | 0.36 | 6.75 | 5.64 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.